- Home
- NXL vs IPDN Comparison
NXL vs IPDN Comparison
Compare NXL & IPDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- IPDN
- Stock Information
- Founded
- NXL 2010
- IPDN 2003
- Country
- NXL United States
- IPDN United States
- Employees
- NXL N/A
- IPDN N/A
- Industry
- NXL Medical Specialities
- IPDN EDP Services
- Sector
- NXL Health Care
- IPDN Technology
- Exchange
- NXL Nasdaq
- IPDN Nasdaq
- Market Cap
- NXL 10.0M
- IPDN 11.1M
- IPO Year
- NXL 2022
- IPDN 2013
- Fundamental
- Price
- NXL $3.92
- IPDN $0.92
- Analyst Decision
- NXL Strong Buy
- IPDN
- Analyst Count
- NXL 1
- IPDN 0
- Target Price
- NXL $3.00
- IPDN N/A
- AVG Volume (30 Days)
- NXL 4.3M
- IPDN 20.5K
- Earning Date
- NXL 11-08-2024
- IPDN 11-22-2024
- Dividend Yield
- NXL N/A
- IPDN N/A
- EPS Growth
- NXL N/A
- IPDN N/A
- EPS
- NXL N/A
- IPDN N/A
- Revenue
- NXL $162,078.00
- IPDN $7,319,905.00
- Revenue This Year
- NXL $51.39
- IPDN N/A
- Revenue Next Year
- NXL $177.11
- IPDN N/A
- P/E Ratio
- NXL N/A
- IPDN N/A
- Revenue Growth
- NXL 26.00
- IPDN N/A
- 52 Week Low
- NXL $0.25
- IPDN $0.42
- 52 Week High
- NXL $4.36
- IPDN $3.01
- Technical
- Relative Strength Index (RSI)
- NXL 68.88
- IPDN 55.52
- Support Level
- NXL $2.40
- IPDN $0.66
- Resistance Level
- NXL $4.36
- IPDN $0.90
- Average True Range (ATR)
- NXL 0.63
- IPDN 0.09
- MACD
- NXL 0.08
- IPDN -0.01
- Stochastic Oscillator
- NXL 79.19
- IPDN 67.07
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.